|
1
|
Greenhill C: Thyroid function:
Hyperthyroidism - psychiatric issues. Nat Rev Endocrinol.
10:652014. View Article : Google Scholar
|
|
2
|
Brandt F, Thvilum M, Almind D, et al:
Hyperthyroidism and psychiatric morbidity: Evidence from a Danish
nationwide register study. Eur J Endocrinol. 170:341–348. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ertek S and Cicero AF: Hyperthyroidism and
cardiovascular complications: A narrative review on the basis of
pathophysiology. Arch Med Sci. 9:944–952. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bajwa SJ and Sehgal V: Anesthesia and
thyroid surgery: The never ending challenges. Indian J Endocrinol
Metab. 17:228–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsubokawa T, Yamamoto K and Kobayashi T:
Propofol clearance and distribution volume increase in patients
with hyperthyroidism. Anesth Analg. 87:195–199. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang YG, Song XJ, Feng SW, Ge YL, Yang JJ
and He LL: Hyperthyroidism patients have shorter onset and duration
time of rocuronium than euthyroidism patients. J Pharm Pharm Sci.
10:53–60. 2007.PubMed/NCBI
|
|
7
|
Kumar VV and Kaimar P: Subclinical
hypothyroidism: A cause for delayed recovery from anaesthesia?
Indian. J Anaesth. 55:433–434. 2011.
|
|
8
|
Trapani G, Altomare C, Liso G, Sanna E and
Biggio G: Propofol in anesthesia. Mechanism of action,
structure-activity relationships, and drug delivery. Curr Med Chem.
7:249–271. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hara M, Kai Y and Ikemoto Y: Enhancement
by propofol of the gamma-aminobutyric acid A response in
dissociated hippocampal pyramidal neurons of the rat.
Anesthesiology. 81:988–994. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Olsen RW and Sieghart W: International
Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid (A)
receptors: classification on the basis of subunit composition,
pharmacology, and function. Update. Pharmacol Rev. 60:243–260.
2008. View Article : Google Scholar
|
|
11
|
Duveau V, Laustela S, Barth L, et al:
Spatiotemporal specificity of GABAA receptor-mediated
regulation of adult hippocampal neurogenesis. Eur J Neurosci.
34:362–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olsen RW and Sieghart W: GABA A receptors:
Subtypes provide diversity of function and pharmacology.
Neuropharmacology. 56:141–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gupta MK and Misra K: Atom-based 3D-QSAR,
molecular docking and molecular dynamics simulation assessment of
inhibitors for thyroid hormone receptor α and β. J Mol Model.
20:22862014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Puia G and Losi G: Thyroid hormones
modulate GABA(A) receptor-mediated currents in hippocampal neurons.
Neuropharmacology. 60:1254–1261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li M, Iismaa SE, Naqvi N, Nicks A, Husain
A and Graham RM: Thyroid hormone action in postnatal heart
development. Stem Cell Res (Amst). 13:582–591. 2014. View Article : Google Scholar
|
|
16
|
Wirth EK, Schweizer U and Köhrle J:
Transport of thyroid hormone in brain. Front Endocrinol (Lausanne).
5:982014.PubMed/NCBI
|
|
17
|
Morte B and Bernal J: Thyroid hormone
action: Astrocyte-neuron communication. Front Endocrinol
(Lausanne). 5:822014.PubMed/NCBI
|
|
18
|
Bhumika S and Darras VM: Role of thyroid
hormones in different aspects of nervous system regeneration in
vertebrates. Gen Comp Endocrinol. 203:86–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Davis PJ, Tillmann HC, Davis FB and
Wehling M: Comparison of the mechanisms of nongenomic actions of
thyroid hormone and steroid hormones. J Endocrinol Invest.
25:377–388. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bergh JJ, Lin HY, Lansing L, et al:
Integrin alphaVbeta3 contains a cell surface receptor site for
thyroid hormone that is linked to activation of mitogen-activated
protein kinase and induction of angiogenesis. Endocrinology.
146:2864–2871. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davis PJ, Davis FB and Cody V: Membrane
receptors mediating thyroid hormone action. Trends Endocrinol
Metab. 16:429–435. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin HY, Sun M, Tang HY, et al: L-Thyroxine
vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: Activation
of mitogen-activated protein kinase and phosphatidylinositol
3-kinase. Am J Physiol Cell Physiol. 296:C980–C991. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cohen K, Ellis M, Khoury S, Davis PJ,
Hercbergs A and Ashur-Fabian O: Thyroid hormone is a MAPK-dependent
growth factor for human myeloma cells acting via αvβ3 integrin. Mol
Cancer Res. 9:1385–1394. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luidens MK, Mousa SA, Davis FB, Lin HY and
Davis PJ: Thyroid hormone and angiogenesis. Vascul Pharmacol.
52:142–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sukocheva OA and Carpenter DO:
Anti-apoptotic effects of 3,5,3′-tri-iodothyronine in mouse
hepatocytes. J Endocrinol. 191:447–458. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hausenloy DJ and Yellon DM: New directions
for protecting the heart against ischaemia-reperfusion injury:
Targeting the reperfusion injury salvage kinase (RISK)-pathway.
Cardiovasc Res. 61:448–460. 2004. View Article : Google Scholar : PubMed/NCBI
|
